Whittle, SL and Colebatch, AN and Buchbinder, R and Edwards, CJ and Adams, K and Englbrecht, M and Hazlewood, G and Marks, JL and Radner, H and Ramiro, S and Richards, BL and Tarner, IH and Aletaha, D and Bombardier, C and Landewe, RB and Muller-Ladner, U and Bijlsma, JWJ and Branco, JC and Bykerk, VP and da Rocha Castelar Pinheiro, G and Catrina, AI and Hannonen, P and Kiely, P and Leeb, B and Lie, E and Martinez-Osuna, P and Montecucco, C and Ostergaard, M and Westhovens, R and Zochling, J and van der Heijde, D, Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative, Rheumatology, 51, (8) pp. 1416-1425. ISSN 1462-0324 (2012) [Refereed Article]
Licensed under Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0) http://creativecommons.org/licenses/by-nc/3.0/
Objective: To develop evidence-based recommendations for pain management by pharmacotherapy in patients with inflammatory arthritis (IA).Methods: A total of 453 rheumatologists from 17 countries participated in the 2010 3e (Evidence, Expertise, Exchange) Initiative. Using a formal voting process, 89 rheumatologists representing all 17 countries selected 10 clinical questions regarding the use of pain medications in IA. Bibliographic fellows undertook a systematic literature review for each question, using MEDLINE, EMBASE, Cochrane CENTRAL and 2008-09 European League Against Rheumatism (EULAR)/ACR abstracts. Relevant studies were retrieved for data extraction and quality assessment. Rheumatologists from each country used this evidence to develop a set of national recommendations. Multinational recommendations were then formulated and assessed for agreement and the potential impact on clinical practice.
Results: A total of 49 242 references were identified, from which 167 studies were included in the systematic reviews. One clinical question regarding different comorbidities was divided into two separate reviews, resulting in 11 recommendations in total. Oxford levels of evidence were applied to each recommendation. The recommendations related to the efficacy and safety of various analgesic medications, pain measurement scales and pain management in the pre-conception period, pregnancy and lactation. Finally, an algorithm for the pharmacological management of pain in IA was developed. Twenty per cent of rheumatologists reported that the algorithm would change their practice, and 75% felt the algorithm was in accordance with their current practice.Conclusions: Eleven evidence-based recommendations on the management of pain by pharmacotherapy in IA were developed. They are supported by a large panel of rheumatologists from 17 countries, thus enhancing their utility in clinical practice.
|Item Type:||Refereed Article|
|Keywords:||arthritis, evidence-based medicine, analgesics|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Clinical sciences|
|Research Field:||Rheumatology and arthritis|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Zochling, J (Dr Jane Zochling)|
|Web of Science® Times Cited:||40|
|Deposited By:||Menzies Institute for Medical Research|
|Downloads:||300 View Download Statistics|
Repository Staff Only: item control page